| Name | Ki 67 |
|---|---|
| Synonyms | Antigen KI 67; Antigen identified by monoclonal antibody Ki 67; KIA; Ki 67; MKI67; Proliferation related Ki 67 antigen; Antigen identified by monoclonal antibody Ki 67s; Ki 67s… |
| Name | ACC |
|---|---|
| CAS | 1-aminocyclopropanecarboxylic acid |
| PubMed | Abstract | RScore(About this table) | |
|---|---|---|---|
| 18248354 | Vargas PA, Cheng Y, Barrett AW, Craig GT, Speight PM: Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. J Oral Pathol Med. 2008 May;37(5):309-18. Epub 2008 Jan 30. |
4(0,0,0,4) | Details |
| 18366613 | Yang JY, Yang MQ, Luo Z, Ma Y, Li J, Deng Y, Huang X: A hybrid machine learning-based method for classifying the Cushing's Syndrome with comorbid adrenocortical lesions. BMC Genomics. 2008;9 Suppl 1:S23. It follows from a comprehensive statistical analysis that a number of antigens such as hTERT, PCNA and Ki-67 can be considered as cancer markers, while another set of antigens such as P27KIP1 and FHIT are possible markers for normal tissue. |
3(0,0,0,3) | Details |
| 18326020 | Vekony H, Raaphorst FM, Otte AP, van Lohuizen M, Leemans CR, van der Waal I, Bloemena E: High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma. J Clin Pathol. 2008 Jun;61(6):744-9. Epub 2008 Mar 6. METHODS: Expression of the cell cycle proteins p53, cyclin D1, p16 (INK4a), E2F1 and Ki-67, together with the Polycomb group (PcG) proteins BMI-1, MEL-18, EZH2 and EED was investigated immunohistochemically 21 formalin-fixed, paraffin-embedded primary ACCs in relation to tumour characteristics. |
2(0,0,0,2) | Details |
| 18515402 | Advani A, Vaikkakara S, Gill MS, Arun CS, Pearce SH, Ball SG, James RA, Lennard TW, Bliss RD, Quinton R, Johnson SJ: Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review. J Clin Pathol. 2008 Aug;61(8):939-44. Epub 2008 May 30. A systematic evaluation of Ki-67 immunolabelling was also performed. |
1(0,0,0,1) | Details |
| 17974017 | Vakkala M, Laurila JJ, Saarnio J, Koivukangas V, Syrjala H, Karttunen T, Soini Y, Ala-Kokko TI: Cellular turnover and expression of hypoxic-inducible factor in acute acalculous and calculous cholecystitis. Crit Care. 2007;11(5):R116. The immunohistochemical stains included antibodies to Ki-67 (proliferation), M30 (apoptosis) and HIF-1alpha. |
1(0,0,0,1) | Details |
| 18059225 | Seethala RR, Hunt JL, Baloch ZW, Livolsi VA, Leon Barnes E: Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol. 2007 Nov;31(11):1683-94. Ki-67 and p53 labeling indices were elevated in the high-grade components, though c-kit and cyclin-D1 were not. |
1(0,0,0,1) | Details |
| 19955217 | Luconi M, Mangoni M, Gelmini S, Poli G, Nesi G, Francalanci M, Pratesi N, Cantini G, Lombardi A, Pepi M, Ercolino T, Serio M, Orlando C, Mannelli M: impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. Endocr Relat Cancer. 2010 Feb 18;17(1):169-77. Print 2010 Mar. Tumor immunohistochemistry showed that Ki-67 was reduced in RGZ versus control group. |
1(0,0,0,1) | Details |
| 20016788 | Malhotra KP, Agrawal V, Pandey R: High Grade Transformation in Adenoid Cystic Carcinoma of the Parotid: Report of a Case with Cytologic, Histologic and Immunohistochemical Study. Head Neck Pathol. 2009 Dec;3(4):310-314. Epub 2009 Jun 20. Immunohistochemical study of the undifferentiated component as compared to conventional ACC showed greater over-expression of p53 and Ki-67. |
1(0,0,0,1) | Details |